4//SEC Filing
NOVIT, L.P. 4
Accession 0001437749-20-019217
CIK 0000922247other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:03 PM ET
Size
9.9 KB
Accession
0001437749-20-019217
Insider Transaction Report
Form 4
Novit U.S., Inc.
10% Owner
Transactions
- Purchase
Warrant to Purchase Common Stock
2020-08-27+10,000,000→ 10,000,000 totalExercise: $0.15From: 2020-08-27Exp: 2027-08-27→ Common Stock (10,000,000 underlying) - Purchase
Common Stock
2020-08-27+10,000,000→ 21,517,582 total
NOVIT, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2020-08-27+10,000,000→ 21,517,582 total - Purchase
Warrant to Purchase Common Stock
2020-08-27+10,000,000→ 10,000,000 totalExercise: $0.15From: 2020-08-27Exp: 2027-08-27→ Common Stock (10,000,000 underlying)
Kusmierz Katarzyna
10% Owner
Transactions
- Purchase
Common Stock
2020-08-27+10,000,000→ 21,517,582 total - Purchase
Warrant to Purchase Common Stock
2020-08-27+10,000,000→ 10,000,000 totalExercise: $0.15From: 2020-08-27Exp: 2027-08-27→ Common Stock (10,000,000 underlying)
Footnotes (2)
- [F1]The reported securities consist of 10,000,000 "Units" purchased by the reporting person for $0.10 per Unit. Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock.
- [F2]Represents securities directly owned by Novit, L.P. ("Novit"). Each of the other Reporting Persons are indirect beneficial owners of such securities as follows: Novit U.S., Inc. is the general partner of Novit, and Katarzyna Kusmierz is the trustee of the NAP Trust and VN Trust, which indirectly own all of the outstanding partnership interests in Novit.
Documents
Issuer
Cyclo Therapeutics, Inc.
CIK 0000922247
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001606624
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:03 PM ET
- Size
- 9.9 KB